-
Most Recent
Search Results
240 results for abb
AbbVie Will Be in Big Trouble When Its Patent Cliff Arrives
ABBV stock may seem like an attractive value name. But while it is very profitable now, things are set to worsen dramatically in a few…
Hold Recommendation for AbbVie (ABBV) Stock Kept
Currently, AbbVie Inc (NYSE:ABBV) has a Hold using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing approach. This represents no change…
3 Things Driving AbbVie Inc. Stock After Q4 Earnings Report
AbbVie Inc. (NYSE:ABBV) reported fourth-quarter and full-year earnings Friday morning, and AbbVie stock responded by jumping more than 10% in early trading. What did the…
AbbVie Inc (ABBV) Stock STILL Has Much More Room to Run Higher
ABBV stock has a lot more long-term oomph when you consider its current pipeline. Here’s why investors shouldn’t overlook AbbVie.
AbbVie Earnings: 5 Things for ABBV Stock Investors to Know About Q1
AbbVie (ABBV) earnings for the biopharmaceutical company’s first quarter of 2020 have ABBV stock on the move Friday after beating estimates.
Why Vale SA (VALE), Lululemon Athletica Inc. (LULU) and AbbVie Inc. (ABBV) Are 3 of Today’s Worst Stocks
AbbVie (ABBV), Lululemon Athletica (LULU) and Vale SA (VALE) led the marketwide bearish charge on Monday.
AbbVie Stock Is a Winner in the Pharmaceutical Industry
The public health crisis threw AbbVie into the spotlight but the company handled the ongoing crisis better than its competitors. With a successful acquisition and…
ABBV Stock Earnings: AbbVie Beats EPS, Beats Revenue for Q2 2024
ABBV stock results show that AbbVie beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
ABBV Stock Earnings: AbbVie Beats EPS, Beats Revenue for Q1 2024
ABBV stock results show that AbbVie beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
AbbVie Stock Jumps Higher on Q3 Earnings Beat
AbbVie stock got a slight boost on Friday following the release of its earnings report for the third quarter of the year.
AbbVie Stands to Benefit from Affluenza
With another wave of coronavirus cases hitting the U.S., AbbVie stock seems a dubious investment. Yet with the acquisition of Allergan and its Botox treatment,…
Best Stocks for 2022: AbbVie Is a Recession-Resistant Dividend King
ABBV stock is one of the best choices you can make for 2022. Even though the company is losing its Humira patent soon, it isn’t…
AbbVie News: 5 Things for ABBV Investors to Know About Q3
AbbVie (ABBV) news for Friday includes results from the biopharmaceutical company’s earnings report for the third quarter of 2020.
Why Best Buy Co Inc (BBY), AbbVie Inc (ABBV), Smith & Wesson Holding Corp (SWHC) are Three of Today’s Worst Stocks
Smith & Wesson (SWHC), Best Buy (BBY) and AbbVie (ABBV) got the new trading week started on the wrong foot.
Don’t Chase AbbVie Inc Stock After Its Huge Earnings Win
AbbVie’s Q4 beat shows a company operating on all cylinders. But the nature of the drug space shows that’s precisely when long-term investors need to…
Biopharma News: IMAB Stock Soars 4% on AbbVie Pact
I-Mab (IMAB) is seeing gains to IMAB stock on Friday after the biopharma company announced news of a deal with AbbVie (ABBV).
AbbVie Inc (ABBV) Earnings: 12 Things to Know
AbbVie (ABBV) has released its earnings report for the third quarter of 2017 and ‘InvestorPlace’ has a few things to know about it.
Earnings Momentum Analytics Power AbbVie (ABBV) to Strong Buy
The current recommendation of Strong Buy for AbbVie Inc (NYSE:ABBV) has been derived by using Louis Navellier’s Portfolio Grader stock evaluator, which incorporates his investing…
AbbVie (ABBV) a Strong Buy on Top-End Earnings Momentum
Portfolio Grader currently ranks AbbVie Inc (NYSE:ABBV) a Strong Buy. The methods for fundamental and quantitative metrics used in this analytical tool, developed by Louis…
AbbVie Inc (ABBV) Is About to Steamroll the Competition
Good news for AbbVie (ABBV) shareholders: The pharmaceutical company just entered the Hepatitis C. market, while reinforcing its position in the psoriasis area. Given ABBV’s…
It’s Time to Buy AbbVie Stock Now After Its Allergan Purchase
AbbVie stock needed its merger with AGN stock to diversify. Now that it has, the stock has more potential upside thanks to Allergan.
Trade of the Day: AbbVie Inc. (NYSE:ABBV)
AbbVie has a great opportunity for growth in developing and commercialize BioArctic’s treatment platform for neurodegenerative diseases.
Why You Should Buy ABBV Stock for Income and Value
Although there could be further weakness in the AbbVie stock price in the coming months, ABBV stock belongs in a diversified portfolio.
LinkedIn Corporation, AbbVie Inc., and Starbucks Corporation Move Big on Earnings
LinkedIn Corporation (LNKD), AbbVie Inc. (ABBV) and Starbucks Corporation (SBUX) move big in the stock market today after reporting earnings
4 – 10 of 240 results
